MolMed now part of AGC Biologics
Developing innovative anti-tumor therapies
- B2B
About MolMed now part of AGC Biologics
Clinical stage biotech company specializing in developing innovative anti-tumor therapies and cell & gene technologies for hematological malignancies and solid tumors
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- milano, lombardia, Italy
- Founded
- 1996
- Revenue
- $6.1M – $48.4MTamtam estimate
- Website
- agcbio.com
- linkedin.com/company/molmed
MolMed now part of AGC Biologics at a glance
MolMed now part of AGC Biologics is a B2B company in the Biotechnology Research industry, headquartered in milano, lombardia, Italy.
MolMed now part of AGC Biologics was founded in 1996.
MolMed now part of AGC Biologics has 11–50 employees.
MolMed now part of AGC Biologics's revenue is $6.1M – $48.4M (Tamtam estimate).
Frequently asked questions about MolMed now part of AGC Biologics
What is MolMed now part of AGC Biologics's revenue?
Tamtam estimates MolMed now part of AGC Biologics's annual revenue at $6.1M – $48.4M.
How many employees does MolMed now part of AGC Biologics have?
MolMed now part of AGC Biologics has 11–50 employees.
Where is MolMed now part of AGC Biologics headquartered?
MolMed now part of AGC Biologics is headquartered in milano, lombardia, Italy.
Selling to companies like MolMed now part of AGC Biologics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies